EUCTR2014-000311-13-FR进行中（未招募）1 期
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients aged 70 years and older : a Randomized Placebo-Controlled Study - SYMPTOMS
CHRU de Brest0 个研究点目标入组 5,030 人开始时间: 2015年6月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 5,030
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patient aged 75 years or older
- •Admitted to hospital for an acute medical illness
- •Anticipated duration of hospitalization of at least 4 days
- •Life expectancy of at least 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5030
排除标准
- •Admission for one of the following reasons:
- •oPlanned medical procedure.
- •oRoutine health assessment requiring admission for baseline/trending of health status (e.g., routine colonoscopy).
- •oAdmission encountered for another life circumstance that causes no bearing on health status and requires no medical intervention (e.g., lack of housing, economic inadequacy, care-giver respite, family circumstances, administrative).
- •Hypersensitivity to heparin
- •History of Heparin Induced Thrombocytopenia
- •Active bleeding
- •Bacterial endocarditis
- •Platelet count of less than 100,000 per cubic millimeter
- •Patients who require anticoagulant therapy for any indication, and those who received any type of anticoagulant therapy for > 48 hours
- •Active peptic ulcer
- •Concomitant use of aspirin (> 160 mg/day), clopidogrel (> 75 mg/day), or of combined antiplatelet therapy
- •Previous admission to hospital within the last month
- •Creatinine clearance < 15 ml/min
- •Unable or unwilling to consent
- •Ischemic stroke + hemorrhagic transformation
- •Patient requiring admission to Intensive Care Unit
研究者
相似试验
招募中
不适用
The prevention of venous thromboembolization following by using elastic bandageVenous thromboembolizationJPRN-UMIN000043886iigata University Graduate School300
尚未招募
4 期
Prophylaxis of venous thromboembolism in patients with a fracture of the lower extremity being treated conservatively with a below-knee plaster cast.thrombosis10014523pulmonary embolismNL-OMON39940Vrije Universiteit Medisch Centrum670
进行中（未招募）
1 期
Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment.Stage IV colon or rectal adenocarcinoma (mCRC).MedDRA version: 21.1Level: LLTClassification code: 10043565Term: Thromboembolic event Class: 10047065MedDRA version: 21.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864CTIS2023-508860-31-00Grupo Gallego De Investigacion En Tumores Digestivos631
进行中（未招募）
不适用
Prevention of venous thromboembolism in patients with intracranial hemorrhageSpontaneous intracranial hemorrhageMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-002992-40-ITIVERSITA' DEGLI STUDI DI PERUGIA
已完成
不适用
Prevention of venous thromboembolism using thromboprophylactic- transcutaneous electrical nerve stimulatioPatients who undergo total knee arthroplastyJPRN-UMIN000006932Department of Orthopaedic Surgery, Kochi Medical School, Kochi University86